Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 24, 2021 - Issue 2
522
Views
8
CrossRef citations to date
0
Altmetric
Articles

The association of blood non-esterified fatty acid, saturated fatty acids, and polyunsaturated fatty acids levels with mild cognitive impairment in Chinese population aged 35–64 years: a cross-sectional study

, , , &

References

  • Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018 Jan 16;90(3):126–35. doi:10.1212/WNL.0000000000004826.
  • Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014 Mar;275(3):214–28. doi:10.1111/joim.12190.
  • Mortamais M, Portet F, Brickman AM, Provenzano FA, Muraskin J, Akbaraly TN, et al. Education modulates the impact of white matter lesions on the risk of mild cognitive impairment and dementia. Am J Geriatr Psychiatry. 2014 Nov;22(11):1336–45. doi:10.1016/j.jagp.2013.06.002.
  • Ma F, Wu TF, Zhao JG, Ji L, Song AL, Zhang ML, et al. Prevalence of mild cognitive impairment and its subtypes among Chinese older adults: role of vascular risk factors. Dement Geriatr Cogn Disord. 2016;41(5–6):261–72. doi:10.1159/000446507.
  • Yatawara C, Hiu S, Tan L, Kandiah N. Neuropsychiatric symptoms in South-East Asian patients with mild cognitive impairment and dementia: prevalence, subtypes, and risk factors. Int J Geriatr Psychatry. 2018 Jan;33(1):122–30. doi:10.1002/gps.4693.
  • Suarez Bagnasco M. Psychological issues and cognitive impairment in adults with familial hypercholesterolemia. Fam Pract. 2017;34(5):520–24. doi:10.1093/fampra/cmx052.
  • Roberts RO, Knopman DS, Geda YE, Cha RH, Roger VL, Petersen RC. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging. 2010 Nov;31(11):1894–902. doi:10.1016/j.neurobiolaging.2008.10.018.
  • Ramos-Rodriguez JJ, Ortiz O, Jimenez-Palomares M, Kay KR, Berrocoso E, Murillo-Carretero MI, et al. Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. Psychoneuroendocrinology. 2013 Nov;38(11):2462–75. doi:10.1016/j.psyneuen.2013.05.010.
  • Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD, et al. Pulse pressure in relation to Tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol. 2015 May;72(5):546–53. doi:10.1001/jamaneurol.2014.4477.
  • Gibson EL, Barr S, Jeanes YM. Habitual fat intake predicts memory function in younger women. Front Hum Neurosci. 2013;7:838. doi:10.3389/fnhum.2013.00838.
  • Cederholm T, Palmblad J. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care. 2010 Mar;13(2):150–55. doi:10.1097/MCO.0b013e328335c40b.
  • Bo Y, Zhang X, Wang Y, You J, Cui H, Zhu Y, et al. The n-3 polyunsaturated fatty acids supplementation improved the cognitive function in the Chinese elderly with mild cognitive impairment: a double-blind randomized controlled trial. Nutrients. 2017 Jan 10;9(1):54. doi:10.3390/nu9010054.
  • Abderrahim O, Fredrik J, Helga R, David SA, De JCA. Omega-3 fatty acid status enhances the prevention of cognitive decline by B vitamins in mild cognitive impairment. J Alzheimers Dis. 2016;50(2):547–57 doi: 10.3233/JAD-150777
  • Cunnane SC, Schneider JA, Tangney C, Tremblay-Mercier J, Fortier M, Bennett DA, et al. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2012;29(3):691–97. doi:10.3233/JAD-2012-110629.
  • Kuriki K, Nagaya T, Tokudome Y, Imaeda N, Fujiwara N, Sato J, et al. Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. J Nutr. 2003 Nov;133(11):3643–50. doi:10.1093/jn/133.11.3643.
  • Hodson L, Eyles HC, McLachlan KJ, Bell ML, Green TJ, Skeaff CM. Plasma and erythrocyte fatty acids reflect intakes of saturated and n-6 PUFA within a similar time frame. J Nutr. 2014 Jan;144(1):33–41. doi:10.3945/jn.113.183749.
  • Yuan L, Zhen J, Ma W, Cai C, Huang X, Xiao R. The erythrocyte fatty acid profile and cognitive function in old Chinese adults. Nutrients. 2016 Jun 23;8(7):385. doi:10.3390/nu8070385.
  • Toro P, Degen C, Pierer M, Gustafson D, Schroder J, Schonknecht P. Cholesterol in mild cognitive impairment and Alzheimer’s disease in a birth cohort over 14 years. Eur Arch Psychiatry Clin Neurosci. 2014 Sep;264(6):485–92. doi:10.1007/s00406-013-0468-2.
  • Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis. 2017;56(1):215–28. doi:10.3233/Jad-160826.
  • Ding BJ, Xiao R, Ma WW, Zhao L, Bi YX, Zhang Y. The association between macronutrient intake and cognition in individuals aged under 65 in China: a cross-sectional study. BMJ Open. 2018 Jan;8(1):e018573. doi:10.1136/bmjopen-2017-018573.
  • Chen C, Lu FC, Department of Disease Control Ministry of Health PRC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36
  • Lu Y, An Y, Guo J, Zhang X, Wang H, Rong H, et al. Dietary intake of nutrients and lifestyle affect the risk of mild cognitive impairment in the Chinese elderly population: a cross-sectional study. Front Behav Neurosci. 2016;10(118):229. doi:10.3389/fnbeh.2016.00229.
  • Lu J, Li D, Li F, Zhou A, Wang F, Zuo X, et al. Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study. J Geriatr Psychiatry Neurol. 2011 Dec;24(4):184–90. doi:10.1177/0891988711422528.
  • Iuliano L, Pacelli A, Ciacciarelli M, Zerbinati C, Fagioli S, Piras F, et al. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2013;36(3):545–53. doi:10.3233/JAD-122224.
  • Laitinen MH, Ngandu T, Rovio S, Helkala EL, Uusitalo U, Viitanen M, et al. Fat intake at midlife and risk of dementia and Alzheimer’s disease: a population-based study. Dement Geriatr Cogn Disord. 2006;22(1):99–107. doi:10.1159/000093478.
  • Greenwood CE, Winocur G. Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake. Behav Neurosci. 1996 Jun;110(3):451–59 doi: 10.1037/0735-7044.110.3.451
  • Little JP, Madeira JM, Klegeris A. The saturated fatty acid palmitate induces human monocytic cell toxicity toward neuronal cells: exploring a possible link between obesity-related metabolic impairments and neuroinflammation. J Alzheimers Dis. 2012;30(Suppl 2):S179–83. doi:10.3233/Jad-2011-111262.
  • Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis. 2006 Sep;23(3):563–72. doi:10.1016/j.nbd.2006.04.013.
  • Mielke MM, Haughey NJ, Bandaru VV, Schech S, Carrick R, Carlson MC, et al. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement. 2010 Sep;6(5):378–85. doi:10.1016/j.jalz.2010.03.014.
  • Zarrouk A, Riedinger JM, Ahmed SH, Hammami S, Chaabane W, Debbabi M, et al. Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia. J Alzheimers Dis. 2015;44(4):1349–59. doi:10.3233/JAD-142046.
  • Cui Y, Chen X, Liu L, Xie W, Wu Y, Wu Q, et al. Gas chromatography-mass spectrometry analysis of the free fatty acids in serum obtained from patients with Alzheimer’s disease. Biomed Mater Eng. 2015;26(Suppl 1):S2165–77. doi:10.3233/bme-151522.
  • Ebbert JO, Jensen MD. Fat depots, free fatty acids, and dyslipidemia. Nutrients. 2013 Feb 7;5(2):498–508. doi:10.3390/nu5020498.
  • Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000 Nov;49(11):1939–45. doi:10.2337/diabetes.49.11.1939.
  • Shao TN, Yin GZ, Yin XL, Wu JQ, Du XD, Zhu HL, et al. Elevated triglyceride levels are associated with cognitive impairments among patients with major depressive disorder. Compr Psychiatry. 2017 May;75:103–09. doi:10.1016/j.comppsych.2017.03.007.
  • Parthasarathy V, Frazier DT, Bettcher BM, Jastrzab L, Chao L, Reed B, et al. Triglycerides are negatively correlated with cognitive function in nondemented aging adults. Neuropsychology. 2017 Sep;31(6):682–88. doi:10.1037/neu0000335.
  • Giuseppe A, Kwang-Mook J, Vitaly V, Nicholas VD, Sarah KM, David HC, et al. Levels of MUFAs and mead acid (nmol/g) in cerebellum of control subjects and subjects with AD2013.
  • Astarita G, Jung KM, Vasilevko V, Dipatrizio NV, Martin SK, Cribbs DH, et al. Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer’s disease. PLoS One. 2011;6(10):e24777. doi:10.1371/journal.pone.0024777.
  • Ulmann L, Mimouni V, Roux S, Porsolt R, Poisson JP. Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostaglandins Leukot Essent Fatty Acids. 2001 Mar;64(3):189–95. doi:10.1054/plef.2001.0260.
  • Sinclair AJ, Begg D, Mathai M, Weisinger RS. Omega 3 fatty acids and the brain: review of studies in depression. Asia Pac J Clin Nutr. 2007;16(Suppl 1):391–97.
  • Zhang Y, Chen J, Qiu J, Li Y, Wang J, Jiao J. Intakes of fish and PUFAs and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. Am J Clin Nutr. 2016;103(2):330. doi: 10.3945/ajcn.115.124081
  • Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, et al. Plasma fatty acid profiles in relation to cognition and gender in Alzheimer’s disease patients during oral omega-3 fatty acid supplementation: the OmegAD study. J Alzheimers Dis. 2015;48(3):805–12. doi:10.3233/JAD-150102.
  • Wang ZJ, Liang CL, Li GM, Yu CY, Yin M. Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices. Chem Biol Interact. 2006 Nov 7;163(3):207–17. doi:10.1016/j.cbi.2006.08.005.
  • Hajjar T, Goh YM, Rajion MA, Ebrahim M, Vidyadaran S, Fauziah O. The effect of n-3 long chain polyunsaturated fatty acids (LC – PUFA) on cognitive function development in rats. Proceeding of the International Conference on Animal Health and Human Safety; 2013.
  • Loef M, Walach H. The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence. J Nutr Gerontol Geriatr. 2013;32(1):1–23. doi:10.1080/21551197.2012.752335.
  • Milte CM, Sinn N, Street SJ, Buckley JD, Coates AM, Howe PR. Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls. Prostaglandins Leukot Essent Fatty Acids. 2011 May–Jun;84(5–6):153–61. doi:10.1016/j.plefa.2011.02.002.
  • Danthiir V, Hosking D, Burns NR, Wilson C, Nettelbeck T, Calvaresi E, et al. Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids. J Nutr. 2014;144(3):311–20 doi: 10.3945/jn.113.175695
  • Iuliano L, Palmaccio G, Bottaccioli A, Zerbinati C. N3 fatty acids and neurodegeneration: is it enough to stop or to shift? J Alzheimers Dis Parkinsonism. 2012;2(3): e119. doi:10.4172/2161-0460.1000e119.
  • Baleztena J, Ruiz-Canela M, Sayon-Orea C, Pardo M, Anorbe T, Gost JI, et al. Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in ≥75 years old patients: a randomized multicenter study. PLoS One. 2018;13(3):e0193568. doi:10.1371/journal.pone.0193568.
  • Joffre C, Nadjar A, Lebbadi M, Calon F, Laye S. n-3 LCPUFA improves cognition: the young, the old and the sick. Prostaglandins Leukot Essent Fatty Acids. 2014 Jul–Aug;91(1–2):1–20. doi:10.1016/j.plefa.2014.05.001.
  • Rochette AD, Spitznagel MB, Strain G, Devlin M, Crosby RD, Mitchell JE, et al. Mild cognitive impairment is prevalent in persons with severe obesity. Obesity (Silver Spring). 2016 Jul;24(7):1427–29. doi:10.1002/oby.21514.
  • Kato T, Ito K, Fujiwara K, Yamada T, Nakamura A, Arahata Y, et al. Association of cognitive decline with cerebral metabolism and education in amnestic MCI: implications for the cognitive reserve hypothesis. Alzheimers Dement. 2012;8(4):P533. doi: 10.1016/j.jalz.2012.05.1432
  • Durazzo TC, Korecka M, Trojanowski JQ, Weiner MW, Hara RO, Ashford JW, et al. Active cigarette smoking in cognitively-normal elders and probable Alzheimer’s disease is associated with elevated cerebrospinal fluid oxidative stress biomarkers. J Alzheimers Dis. 2016;54(1):99–107. doi:10.3233/Jad-160413.
  • Gons RAR, van Norden AGW, de Laat KF, van Oudheusden LJB, van Uden IWM, Zwiers MP, et al. Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. Brain. 2011 Jul;134(Pt 7):2116–24. doi:10.1093/brain/awr145.
  • Bae JB, Han JW, Kwak KP, Kim BJ, Kim SG, Kim JL, et al. Impact of mild cognitive impairment on mortality and cause of death in the elderly. J Alzheimers Dis. 2018;64(2):607–16. doi:10.3233/JAD-171182.
  • Sujin K, Yongjoo K, Min PS. Association between alcohol drinking behaviour and cognitive function: results from a nationwide longitudinal study of South Korea. Bmj Open. 2016;6(4):e010494. doi: 10.1136/bmjopen-2015-010494
  • Xu G, Liu X, Yin Q, Zhu W, Zhang R, Fan X. Alcohol consumption and transition of mild cognitive impairment to dementia. Psychiatry Clin Neurosci. 2009;63(1):43–49. doi: 10.1111/j.1440-1819.2008.01904.x
  • Stampfer MJ, Kang JH, Chen J, Cherry R, Grodstein F. Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med. 2005 Jan 20;352(3):245–53. doi:10.1056/NEJMoa041152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.